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The relationship between lower urinary tract symptoms (LUTS) and common mental health
disorders such as depression and anxiety in men remains unclear. Inflammation has
recently been identified as an independent risk factor for LUTS and depression. This study
aimed to assess the association between depression, anxiety and LUTS, and the moderat-
ing influence of systemic inflammation, in the presence of other biopsychosocial
confounders.
Methods
Participants were randomly-selected from urban, community-dwelling males aged 35–80
years at recruitment (n = 1195; sample response rate:67.8%). Of these, 730 men who
attended baseline (2002–5) and follow-up clinic visits (2007–10), with complete outcome
measures, and without prostate or bladder cancer and/or surgery, neurodegenerative con-
ditions, or antipsychotic medications use, were selected for the present study. Unadjusted
and multi-adjusted regression models of incident storage and voiding LUTS and incident
depression and anxiety were combined with serum inflammatory markers (high-sensitive
C-reactive protein (hsCRP), tumor necrosis factor-alpha (TNF-α), interleukin–6 (IL–6), mye-
loperoxidase (MPO), soluble e-selectin (e-Sel)) and socio-demographic, lifestyle, and
health-related factors. Hierarchical multiple regression was used to assessed the moderat-
ing effect of inflammatory markers.
Results
The incidence of storage, voiding LUTS, depression and anxiety was 16.3% (n = 108),
12.1% (n = 88), 14.5% (n = 108), and 12.2% (n = 107). Regression models demonstrated
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that men with depression and anxiety at baseline were more likely to have incident storage,
but not voiding LUTS (OR: 1.26, 99%CI: 1.01–4.02; and OR:1.74; 99%CI:1.05–2.21,
respectively). Men with anxiety and storage LUTS at baseline were more likely to have inci-
dent depression (OR: 2.77, 99%CI: 1.65–7.89; and OR:1.45; 99%CI:1.05–2.36, respec-
tively), while men with depression and voiding LUTS were more likely to have anxiety at
follow-up (OR: 5.06, 99%CI: 2.81–9.11; and OR:2.40; 99%CI:1.16–4.98, respectively).
CRP, TNF-α, and e-Sel were found to have significant moderating effects on the develop-
ment of storage LUTS (1.06, 0.91–1.96, R2 change: 12.7%), depression (1.17, 1.01–1.54,
R2 change: 9.8%), and anxiety (1.35, 1.03–1.76, R2 change: 10.6%), respectively.
Conclusions
There is a bidirectional relationship between storage, but not voiding, LUTS and both
depression and anxiety. We observed variable moderation effects for selected inflammatory
markers on the development of depression, anxiety and storage LUTS.
Introduction
Lower urinary tract symptoms (LUTS) can be broadly classified as storage (increased frequency
and/or urgency of micturition, and nocturia) and voiding (incomplete emptying, intermittent
and/or weak stream, and straining during micturition) symptoms. The prevalence of LUTS in
community-based men ranges from 13–47% of adult males [1]. Storage symptoms are more
common than voiding symptoms (13–42% vs. 6–22% of adult males, respectively [1]). LUTS
has been demonstrated to have an equivalent or greater impact on health-related quality of life
(HR-QoL) as other major chronic diseases, such as heart disease, diabetes, and cancer [2]. Stor-
age symptoms (especially nocturia) in particular seem to adversely impact HR-QoL, while
voiding symptoms are associated with elevated distress [1].
Common mental health disorders, such as depression and anxiety, have similarly adverse
impacts on HR-QoL [3]. Recent global estimates indicate that depressive and anxiety disorders
were the second and sixth leading cause of years lived with disability (YLDs) [3].
While LUTS has traditionally been thought to be solely related to deteriorating bladder
function or prostate abnormalities, recent studies have demonstrated associations between
LUTS and obesity, type 2 diabetes, sleep disorders, arthritis, employment and marital status,
testosterone, smoking and low physical activity, and medication usage (see [4] for review).
Accordingly, LUTS may be indicative of systemic disease, occurring beyond, but impacting on
the lower urinary tract.
Cross-sectional [5] and longitudinal studies [6] have demonstrated an independent associa-
tion between the development depression and anxiety and LUTS in men. However, no study to
date has distinguished between LUTS symptom type, an important distinction given the differ-
ing risk factors for storage and voiding LUTS [7]. Systemic inflammation in particular has been
identified as an independent risk factor for both LUTS [8] and depression /anxiety [9] in ageing
men. C-reactive protein (CRP), interleukin–6 (IL–6), and tumor necrosis factor alpha (TNF-α)
have previously been shown to associate with LUTS, depression and anxiety [8] [9], while mye-
loperoxidase (MPO) has also been linked to the development of depression [9]. The extent to
which this is independent of confounders common to both LUTS and depression /anxiety (e.g.
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obesity, diabetes, arthritis, smoking and alcohol consumption, sedentary behaviour, sleep dis-
orders and medication usage) remains to be determined.
We examine the relationships between LUTS, depression, anxiety, and serum inflammatory
markers in a community-dwelling cohort of middle-aged to elderly men.
Methods
Study design and sampling
Data were obtained from the Florey Adelaide Male Ageing Study (FAMAS), a population-
based prospective cohort study of randomly-selected men from the northern and western sub-
urbs of Adelaide, Australia [10]. A total of 1,620 men aged 35–80 years at recruitment com-
pleted a telephone interview (sample response rate = 67.8%) and 1,195 attended a clinic visit
(T1; clinic response rate = 45.1%) between 2002 and 2005. Comparisons to the 2001 Australian
Census data showed that FAMAS participants matched the population for most key demo-
graphics, although younger groups and never-married men were under-represented and older
participants were over-represented [10]. Follow-up clinic visits using identical protocols were
conducted between 2007 and 2010 (T2; n = 899), as near as practical to five years post the sub-
jects initial visit (mean follow-up period 5.0 ± 0.2 years). Comparison to the 2006 Australian
Census data showed that FAMAS participants were more likely to be older, married and have a
higher level of post-school education [10].
All protocols were approved by the Royal Adelaide Hospital Research Ethics Committee,
with written, informed consent obtained from all participants. This work was funded through
the Australian National Health and Medical Research Council (Project Grant #627227).
Predictor and outcome variables
Lower urinary tract symptoms (LUTS). The seven-item American Urology Association–
Symptom Index (AUA-SI) was used to evaluate the presence of LUTS [11]. Subjects were clas-
sified as having storage symptoms if the sum of their score on AUA-SI items 2, 4 and 7 was 4
(and their score on item 4 (urgency) was 1) and having voiding symptoms if the sum of their
score on AUA-SI items 1, 3, 5 and 6 was 5.
Combined depression and anxiety. Depressive symptoms were assessed using the Beck
Depression Inventory (BDI) [12] and anxiety symptoms were assessed using the Generalised
Anxiety Disorder – 7 (GAD–7) [13]. Classification of symptomatic depression was by BDI scores
of 12, and symptomatic anxiety was by GAD–7 10. Previously diagnosed depression and
anxiety were determined by self-report. Current prescriptions (within 6 months of clinic visit) for
antidepressants and anxiolytics were determined by record linkage with the national Pharmaceu-
tical Benefits Schemes (PBS) database. Classification of ‘Combined Depression’ or ‘Combined
Anxiety’ required the presence of one or more of the following conditions: (1) symptomatic
depression or anxiety (current symptoms), or (2) current prescription for antidepressant or anxi-
olytics medication, or (3) previously diagnosed depression or anxiety.
Moderating variables
Inflammatory markers. C-reactive protein (CRP) was quantitated using a Cobas Integra
automated clinical chemistry analyzer (Roche Diagnostics, Basel, Switzerland). Tumour necro-
sis factor-alpha (TNF-a), and interleukin 6 (IL–6) was quantitated with an enzyme-linked
immunosorbent assay (ELISA) (R&D, Minneapolis, MN). The inter-assay CVs were 2.1% for
CRP, 10.6% for TNF-α, and 7.8% for IL–6. All inflammatory markers were analysed in the
same laboratory with established QC protocols [10].
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Covariate variables
Demographic factors, health status & medication usage. Information on age, education,
marital, occupational, smoking and disease status was obtained by self-report questionnaire
[10]. Medication use was determined by self-report and data linkage with the national medica-
tion registry. Obstructive sleep apnea (OSA) was defined as men with an apnea-hypopnea
index (AHI) of 10 or greater based on overnight polysomnography testing.
Serum assays. Serum samples were drawn between 8 and 11am after a 12-hour overnight
fast. Following venepuncture, samples were immediately placed in an ice slurry for no more
than 3 hours before being immediately processed for long-term storage at -80C. Serum total
testosterone (TT) was measured by a validated stable-isotope dilution LC–MS/MS (inter-assay
CV: 9.3% at 0.43 nmol/L; 8.6% at 1.66 nmol/L, 4.0% at 8.17 nmol/L) and estradiol (E2) (inter-
assay CV: 14% at 23 pmol/L; 4.0% at 83 pmol/L, 6.0% at 408 pmol/L). HDL cholesterol and tri-
glycerides (TG) were measured enzymatically using a Hitachi 911, with LDL cholesterol calcu-
lated using the Friedwald equation (LDL = Total cholesterol (TC)—HDL—TG/5.0)
(Boehringer, Germany; inter-assay CV: triglyceride 3%, total cholesterol 2.3%, HDL 6.7% and
LDL 3.7%). Plasma glucose was determined using an automated chemistry analyser system
(Olympus AU5400, Japan; inter-assay CV: 2.5% at 3.5 mmol/L and 3.0% at 19.6 mmol/L). Gly-
cated haemoglobin (HbA1c) was measured by high-pressure liquid chromatography (HPLC)
using a spherical cation exchange gel (CV 2% at 6% of total haemoglobin).
Body composition. Anthropometric measures, blood pressure, grip strength and body
composition (by dual energy x-ray absorptiometry (DEXA)) were obtained as previously pub-
lished [10].
Cognitive testing. Given the close association between cognitive function and anxiety /
depression, measures were included that assessed episodic memory function (Fuld Object
Memory Evalutation) and visual attention and task switching (Trail Making Tests A & B) [10].
Statistical analyses. For the present study, only men who had completed the storage and
voiding LUTS questions from the AUA-SI, and all depression / anxiety measures, at T1 & T2
(n = 703, 772 & n = 698, respectively) were included. Based on an initial disease-free incidence of
25% and an exposure prevalence of approximately 15%, this sample size is sufficient to detect an
effect size of between 2.0–3.5 with 99% power. Men with a history of bladder (n = 8) or prostate
cancer (n = 17) or prostate surgery (n = 12), and a current self-reported urinary tract infection
(n = 5) were excluded from the LUTS analysis, while men who were currently ( 6 months of
clinic visit) using anti-psychotic medications (n = 13) or reported having a neurodegenerative
condition (n = 5) were excluded from the depression and anxiety analysis (Fig 1).
Univariable logistic regression assessed the association between covariates and incident
storage, voiding LUTS, depression and anxiety. For the multivariable logistic regression mod-
els, independents were first selected on the basis of demonstrated or suspected associations
with the outcome. Those predictors with a unadjusted association with the outcome variable of
p0.25 were included in the final regression model. Due to multiple regression, the alpha level
was placed at 0.01.
Hierarchical multiple regression was used to assess the moderating influence of all those
inflammatory markers with an unadjusted regression estimate on the outcome of p<0.25. All
predictor variables in these models were centred, with interaction terms included for those with
an a priori association (e.g. storage and voiding LUTS, HDL and LDL cholesterol, age and BMI).
Data were analysed using PASW Statistics 20.0 (SPSS Inc. Chicago, USA), and forest plots
maps modelled by AMOS (SPSS Inc. Chicago, USA).
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Results
Table 1 details the selected demographic and clinical variables of the analytic sample at baseline
and follow-up. At follow-up, men were found to have lower handgrip strength, less full-time
employment and higher rates of retirement, have a lower gross household income, a lower
serum testosterone, higher proportion of sleep apnea, erectile dysfunction, lower solitary and
dyadic sexual desire, and a higher proportion of men with diabetes (Table 1)
Fig 1. Consort diagrams for the final analytical samples for incident storage, voiding LUTS, depression and anxiety in a community cohort of
Australianmen.
doi:10.1371/journal.pone.0137903.g001
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LUTS, depression and anxiety incidence, and inflammatory markers
Table 2 detail the baseline descriptive covariates and regression estimates for incident storage
and voiding LUTS. At follow-up, 16.3% (n = 108) of men reported incident storage symptoms
(19 cases per 1000 person-years), compared with 12.0% (n = 88; 11 cases per 1000 person-
years) for incident voiding LUTS. Men with incident storage and voiding symptoms were more
likely at baseline to have both depression (17.9% (n = 26) & 27.6% (n = 24)) and anxiety
(20.5% (n = 31) & 21.6% (n = 19)), respectively (Table 2).
CRP was higher in men with incident storage LUTS, with no other significant differences
between either storage or voiding LUTS for other inflammatory markers (Table 2).
Of the other covariates, men with incident storage LUTS were found to be older, have higher
BMI, plasma LDL cholesterol, SHBG, E2, T4, and PSA, with lower handgrip strength, plasma
testosterone and erectile function. Men with incident storage LUTS were also more likely to be
widowed, unemployed, retired, have lower physical activity, have measured sleep apnea, and a
previous diagnosis of angina, anxiety, diabetes, and osteoarthritis. Men with incident voiding
LUTS, were older, had higher systolic blood pressure, plasma PSA and lower handgrip
strength, plasma testosterone, dyadic sexual desire and erectile function. Men with incident
voiding LUTS were more likely to be widowed, unemployed, retired, have lower income, and a
previous diagnosis of diabetes and osteoarthritis (S1 Table)
In unadjusted regression models of incident storage LUTS, there was a strong positive asso-
ciation between depression, anxiety, and voiding LUTS (in order of size of effect) at baseline.
When stratified according to middle aged to older men (35–64 years) and elderly men (65–80
years), these effects were strongest in the latter group. In multi-adjusted models, depression,
anxiety, and voiding LUTS at baseline maintained the positive association with the develop-
ment of storage LUTS at follow-up (OR: 1.26 (1.01, 4.02), 1.74 (1.05, 2.21), and 2.63 (1.11,
7.35), respectively).
In unadjusted regression models of incident voiding LUTS, there was a comparable positive
association between depression and anxiety at baseline. Again, these effects were strongest in
elderly (cf. middle aged to older) men. These effects however were not maintained in multi-
adjusted models of voiding LUTS.
An age-adjusted effect was observed for CRP on incident storage LUTS. No other significant
effects of other inflammatory markers were observed in final models of incident storage and
voiding LUTS (Table 2).
Incident depression, anxiety, LUTS and inflammatory markers
Table 3 details the baseline descriptive covariates and regression estimates for incident depres-
sion and anxiety. At follow-up, 14.5% (n = 108) and 12.2% (n = 10) of men reported incident
depression and anxiety, respectively. In unadjusted models of incident depression, there was a
strong positive association between anxiety, and storage LUTS at baseline. When stratified
according to middle aged to older men (35–64 years) and elderly men (65–80 years), these
effects were stronger in the elderly group for anxiety and voiding LUTS, and in the younger
group for storage LUTS. The effect of anxiety and storage LUTS was maintained in multi-
adjusted models of incident depression (OR: 2.7; 99%CI:1.65, 7.89, and 1.45 (1.05, 2.36),
respectively). For incident anxiety, there was a strong positive association between storage,
voiding LUTS, and depression (in order of size of effect) at baseline. These effects were similar
when the sample was stratified into middle aged to older men and elderly men. In multi-
adjusted models, only the effect of depression and voiding LUTS were maintained (5.06 (2.81,
9.11) and 2.40 (1.16, 4.98), respectively).
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Table 1. Baseline (2002–5) and follow-up (2007–10) descriptive characteristics of analytic sample.
Baseline Follow-up
% / x N / SD % / x N / SD p
Age (years) 55 11 60 11 0.001
BMI (kg/m2) 28.5 4.3 28.8 4.5 0.432
Abdominal fat mass Δ (%;DEXA) 33.6 7.7 34.9 7.6 0.254
Hand grip strength *(Dominant; Nm) 49.7 9.5 42.5 9.7 0.031
Systolic BP (mmHg) 137.1 17.71 136.3 16.5 0.212
Diastolic BP (mmHg) 85.4 8.82 84.2 9.73 0.551
Marital status 0.497
Married / Partner 83.9% 733 82.7% 691
Separated / Divorced 9.2% 80 8.9% 74
Widowed 2.5% 22 3.2% 27
Never married 4.5% 39 4.3% 36
Work status 0.021
Full time 56.1% 491 46.7% 388
Part time / Casual 8.9% 78 9.4% 78
Unemployed 2.1% 18 2.2% 18
Retired 25.9% 227 35.9% 298
Educational status 0.373
Bachelor or higher 13.9% 122 18.6% 118
Trade/Apprenticeship 33.7% 295 36.7% 296
Certificate/Diploma 25.6% 224 33.1% 210
Other 25.9% 227 15.0% 105
Household Income 0.044
Low 30.4% 262 32.6% 273
Middle 34.8% 308 32.9% 275
High 33.9% 292 28.1% 235
Leisure time physical activity 0.471
150 mins or more 34.8% 308 34.3% 280
1–149 mins 32.6% 287 36.3% 294
None 24.6% 214 29.4% 200
Smoking status (current) 0.080
Yes 17.2% 151 14.1% 118
No 79.6% 697 84.3% 707
Triglycerides (mmol/L) 1.68 1.19 1.74 1.59 0.232
LDL chol. (mmol/L) 3.5 .9 3.1 1.0 0.411
HDL chol. (mmol/L) 1.2 .3 1.3 .3 0.738
Total T (nmol/L) 17.3 5.8 16.1 5.7 0.050
DHT 1.72 .74 1.65 .69 0.111
SHBG (nmol/L) 34.5 14.8 38.5 16.2 0.151
E2 (pmol/L) 94.7 36.3 91.8 33.8 0.422
T3 (pmol/L) 4.28 .770 4.17 .980 0.561
T4 (pmol/L) 15.7 2.4 15.2 2.5 0.431
TSH (mIU/L) 1.79 2.06 1.73 .92 0.097
PSA *(nmol/L) 1.95 9.06 2.33 3.38 0.115
Sleep apnea (AHI)+ 0.050
AHI <10% 46.2% 157 37.9% 36
AHI 10% 53.8% 183 62.1% 59
(Continued)
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TNF-α and e-Selectin was higher in men with incident depression and anxiety, respectively,
at follow-up (2.535±3.462 pg/mL vs. 2.257±1.516 pg/mL at baseline; and 38.80±16.91 ng/mL
vs. 34.77±13.80). There was no major difference between the unadjusted regression estimates
for either TNF-α or e-Selectin on incident depression and anxiety, respectively, between mid-
dle aged to older and elderly men. These positive associations were maintained in multi-
adjusted models of depression and anxiety for both TNF-α and e-Selectin (Table 3).
Of the other covariates, men with incident depression were found to be older, have higher
abdominal fat mass, plasma LDL cholesterol, and E2, with lower handgrip strength, plasma tes-
tosterone, erectile function and solitary and dyadic sexual desire. Men with incident depression
were also more likely to be widowed, unemployed, retired, lower effective retrievals in memory
testing, and a previous diagnosis of angina. Men with incident anxiety were found to be older,
have higher plasma PSA and gross household income, with lower erectile function, and more
likely to be widowed, retired, have lower physical activity, and a previous diagnosis of angina
(S2 Table).
Effect size moderation of inflammatory markers on incident storage,
voiding LUTS, depression and anxiety
To test for any moderating influence of inflammatory markers, those inflammation covariates
with an unadjusted association with the dependent of p<0.25 were excluded from the final mod-
els (Model 2) and included without the exposure variables (Model 3). For incident storage LUTS,
removing CRP from the final model produced a moderate decrease in the multi-adjusted effect
size of depression (Model 1: 1.26 (1.01, 4.02) to Model 2: 1.18 (0.96, 3.4) and model fit (R2change:
0.253–0.221) (Table 2). For incident depression, removing TNF-α from multi-adjusted models
decreased the size of the effect for anxiety (Model 1: 2.77 (1.65, 7.89) to Model 2: 1.82 (1.02, 2.71)
and increased the observed estimate for storage LUTS (Model 1: 1.45 (1.05, 2.36) to Model 2:
1.98 (1.03, 4.51) and reduced the model fit (R2change: 0.244–0.220). For incident anxiety, remov-
ing e-Selectin attenuated the independent effect of voiding LUTS on anxiety (Model 1: 2.40 (1.16,
4.98) to Model 2: 2.18 (0.96, 4.74), R2 change: 0.190–0.170) (Table 3).
Table 1. (Continued)
Baseline Follow-up
% / x N / SD % / x N / SD p
Erectile Function (IIEF–5) 20.1 8.0 17.3 7.0 0.042
Solitary Sexual Desire *(SDI-II) 7 0.21 5 0.23 0.006
Dyadic Sexual Desire *(SDI-II) 48 0.52 44 0.50 0.039
Health conditions ϕ
Angina 5.3% 46 6.5% 56 0.065
Asthma 12.0% 105 11.3% 97 0.231
Diabetes 10.8% 95 16.6% 14 0.042
Osteoarthritis 8.6% 75 10.5% 90 0.580
Rheumatoid arthritis 4.6% 40 4.5% 39 0.777
Prostate Cancer 3.7% 26 4.8% 40 0.155
Data presented are mean & standard deviation (continuous) or percentage & number (categorical). *Non-normally distributed data are presented as
median & SEM. δ DEXA= dual-energy X-ray absorptiometry; PSA= Prostate-Specific Antigen; + AHI= Apnea-Hypopnea Index; f Health conditions were
determined by participant response to question regarding multiple chronic diseases (“Have you ever been told by a doctor that you have any of the
following conditions?”)
doi:10.1371/journal.pone.0137903.t001
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Table 2. Baseline characteristics andmulti-stage regression estimates for incident storage and voiding LUTS (AUA-SI) in a community-based
cohort of Australianmen.
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Data presented are mean & standard deviation (continuous) or percentage & number (categorical). Non-normally distributed data are presented as
median & SEM.
* Model 1 includes all covariates with a univariate association with the outcome measure of p<0.25
# Identical to Model 1, excluding inflammation markers with a univariate association of p<0.25.
Δ Identical to Model 1, excluding LUTS, anxiety & depression. Full model also adjusted for: (Storage LUTS) age, BMI, handgrip strength, marital status,
work status, household income, recreational exercise level, LDL cholesterol, total testosterone, sleep apnea (AHI>10), diabetes; (Voiding LUTS) As
previous, minus work status, LDL cholesterol, also: HDL cholesterol, serum prostate specific antigen (PSA), erectile dysfunction, angina (see: S1 Table for
confounder univariate and multivariate data).
doi:10.1371/journal.pone.0137903.t002
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Table 3. Baseline characteristics andmulti-stage regression estimates for incident depression & anxiety (diagnosed/symptomatic/medications)
in a community-based cohort of Australianmen.
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Data presented are mean & standard deviation (continuous) or percentage & number (categorical). Non-normally distributed data are presented as median
& SEM.
* Model 1 includes all covariates with a univariate association with the outcome measure of p<0.25
# Identical to Model 1, excluding inflammation markers with a univariate association of p<0.25.
Δ Identical to Model 1, excluding LUTS and depression or anxiety. Full model also adjusted for: (Depression) age category, BMI, handgrip strength, marital
status, work status, household income, recreational exercise level, total testosterone, erectile function, solitary and dyadic sexual desire, sleep apnea
(AHI>10), angina, diabetes; (Anxiety) As previous, minus handgrip strength, sexual desire, diabetes, also: systolic BP, serum prostate specific antigen
(PSA), see: S2 Table for confounder univariate and multivariate data).
doi:10.1371/journal.pone.0137903.t003
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Effect of pharmacotherapy on incident depression, anxiety, storage and
voiding LUTS
Table 4 shows the effect of medication usage on the observed regression coefficients for inci-
dent storage, voiding LUTS, depression and anxiety. Men who had commenced or maintained
both anti-cholinergic and diuretic use at follow-up were more likely to report incident storage
LUTS. Men who had both ceased 5α-reductase inhibitor (5-ARI) prior to follow-up and
deceased 5-ARI usage after baseline assessment, were found at an increased and decreased risk,
respectively, of developing voiding LUTS. Men who had commenced stain usage since baseline
assessment were at a decreased risk for incident storage LUTS and an increased risk for inci-
dent depression. For those men with incident cases of depression (based on self-report and
symptomatic scores only), the commencement or continued use of anxiolytics, and the com-
mencement of antidepressants, contributed significantly to the multivariable model of incident
depression. Likewise, for men with incident cases of anxiety, the commencement or continued
use of anxiolytics was associated with anxiety at follow-up. New or continued use of anxiolytic
was also associated with the development of storage LUTS.
There was no effect of anti-inflammatory usage on either storage, voiding LUTS, depression
or anxiety (Table 4).
Discussion
This longitudinal study of community-dwelling men 35 years or older has demonstrated a bidi-
rectional relationship between the development of LUTS and anxiety and depression, the effect
of which is in part associated with inflammatory markers and dependent on LUTS symptom
type. Incident depression and anxiety was predicted by the prior presence of storage and void-
ing LUTS, respectively. In the case of storage LUTS, this effect on incident depression was asso-
ciated with higher TNF-α, whereas the effect of voiding LUTS on incident anxiety was
independent of elevated e-Selectin. Conversely, incident storage LUTS was predicted by the
presence of both anxiety and depression at baseline, an effect which showed an age-adjusted
association with higher CRP.
LUTS has been shown to be associated with anxiety and depression in a number of cross-
sectional studies [5] [14] [15] but the majority have not distinguished between LUTS clusters.
Only one previous cross-sectional study has shown including voiding-type and post-micturi-
tion symptoms improves the predictive value for depression in men [16], although this cohort
appeared to contain a relatively high amount of men with incomplete emptying (22.3% of men
aged 40–80 years, compared with 9.3% of men from the current study). Recently published
data from a large-scale registry study of Taiwanese men showed a higher likelihood of anxiety
for storage, rather than voiding symptoms, in contrast to the present study. However, this
study defined LUTS from inpatient/outpatient records, included depression in the definition of
the outcome, and was only able to adjust for income and urbanisation. Interestingly, the associ-
ation between anxiety / depression was highest for those men with benign prostatic hyperplasia
(BPH), a condition most commonly associated with voiding LUTS.
To our knowledge, there has been only one longitudinal study exploring the relationship
between storage LUTS and subsequent depression [17]. In this study of 392 South Korean men
aged 65 years or older, 6.2% of men were assessed as having developed depression by multiple
scales (the Geriatric Depression, Centre for Epidemiologic Studies—Depression, and Hamilton
Depression Scales) at follow-up (3 ± 0.3 years), and this was positively associated with storage
symptoms at baseline. We have demonstrated this association with storage LUTS in a large
cohort of men as young as 35 years, including those men who were currently on anti-depres-
sants and/or a previous diagnosis of depression.
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The entire cluster of voiding symptoms has yet to be specifically examined in relation to the
development of either anxiety or depression. A previous study involving a large patient registry
of 16,130 Taiwanese men with BPH, demonstrated that 2.6% of these men had developed
depression after one year of follow-up [18]. Our findings, based on reported urinary symptoms
rather than BPH alone, extend these observations by also including men with significant anxi-
ety at follow-up.
The association between anxiety / depression and LUTS development has been previously
investigated in one cross-sectional [7] and two longitudinal studies [19] [20]. In a cross-sec-
tional study of participants from the Boston Area Community Health (BACH) Survey, men
with incomplete emptying and straining (voiding LUTS) were at a much higher risk of both
mild and severe depression [7]. In a longitudinal study of community-based Chinese men aged
50–70 years, those with depressive symptoms at baseline were 2.8-times more likely to develop
nocturia five years later [19]. While a longitudinal analysis of men with prostate cancer demon-
strated that moderate or higher levels of depression or anxiety were associated with incident
voiding symptoms, although this was confounded by prostatic surgeries. The present study
extends these findings to all urinary storage symptoms (including nocturia), and includes com-
munity-based men who had also been diagnosed with and treated for anxiety.
The effect of age grouping on the development of anxiety, depression, and LUTS produced
mixed results. When stratifying the sample into middle-aged to older and elderly men, the
effect of storage and voiding LUTS was increased and decreased for incident anxiety and
depression, respectively. This is likely a function of the higher prevalence of storage and void-
ing LUTS in younger and older men, respectively, observed by our group [21] and others [22]
[23] [24]. In the case of both incident storage and voiding symptoms, elderly men with anxiety
and depression at baseline were found to have a higher likelihood of troublesome urinary
symptoms at follow-up, This concurs with the bulk of evidence that suggests anxiety / depres-
sion is more likely to present with somatic (as compared with cognitive) symptoms in elderly
men [25] [26]. Given power limitations and our intent to adjust for the multiple confounders
of both LUTS and anxiety / depression, we were unable to test for the differential effect of age
in the final models.
Observations that elevated levels of inflammatory markers are found in patients with anxi-
ety [27] and depression [28], the co-occurrence of anxiety / depression with inflammatory dis-
eases and the increased risk of anxiety / depression with cytokine treatment [29, 30] have
suggested that increased inflammation is associated with a higher risk of mental health disor-
ders in men. For urinary symptoms, increased systemic inflammation (as reflected most often
by higher CRP levels [31]) has been associated with an increased risk of LUTS.
Of the inflammatory markers studied in the present study, CRP, IL–6 and TNF- α have
been previously shown to have an association with depression / anxiety [32] [33]. Our study
also demonstrated an independent, albeit comparatively small effect, of TNF-α on incident
depression / anxiety. TNF- α is known to play an important role in cognitive systems that regu-
late the stress response [34]. Recent studies have demonstrated that elevated TNF- α supresses
the activation of the serotonin receptor subtype 2A (5-HT2A), the only sub-type thought to be
involved in cognition [35]. Furthermore, patients with SSRI-resistant depression show signifi-
cantly higher levels of TNF- α in comparison to healthy controls [34]. To our knowledge, this
study is the first demonstration of a link between TNF- α and incident depression among the
general male population. We also demonstrated elevated markers of endothelial activation (e-
Selectin) in subjects with incident anxiety, independent of either LUTS, depression, or other
confounders. To our knowledge, only one previous study (in diabetic women) has shown an
association with circulating e-Selectin and anxiety [36]. Our findings extend these observations
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to men and demonstrate its utility as an additional biomarker for the development of clini-
cally-significant anxiety.
Our study demonstrated that elevated serum CRP was one mechanism whereby anxiety /
depression may lead to the development of storage LUTS. Previous studies of LUTS in men
have demonstrated a small, [31], or no [37], cross-sectional association between storage LUTS
and CRP in men. The CRP-mediated link between depression/anxiety and the development of
LUTS was not significant after adjustment for other known confounders of LUTS (e.g. hyper-
tension, diabetes, obesity, OSA, widowhood, elevated LDL cholesterol, lower physical activity).
Our modelling confirmed this with a direct, but relatively small, effect of CRP on LUTS devel-
opment in comparison to these other confounders. This indicates that recent suggestions of
improving LUTS outcomes by reducing inflammation is unlikely to be effective in the absence
of appropriate attention to other factors [31].
The strengths of this study include the use of repeated measures from a generally represen-
tative sample of community-dwelling men from the Australian population, the quantification
of multiple inflammatory markers, the examination of both symptomatic and diagnosed anxi-
ety and depression, and the inclusion of a wide variety of bio-psychosocial covariates to control
for potential confounding effects on the outcome measures. The limitations of this study
include a comparatively low sample size for sensitive measures such as cytokines, the possibility
that other inflammatory markers not included may have influenced the development of the
selected outcome measures, the use of the IPSS for LUTS assessment meant some urological
symptoms (e.g. incontinence, pain whilst voiding) were not included, the depression scale used
was not optimised for elderly populations, and the reliance on self-report measures for most
chronic conditions and demographic data.
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